Q32 Bio (QTTB) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.50% |
| Dec 31, 2025 | 38.05% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 49.06% |
| Mar 31, 2025 | 51.61% |
| Dec 31, 2024 | -204.35% |
| Sep 30, 2024 | 19.34% |
| Jun 30, 2024 | -53.06% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 85.36% |
| Sep 30, 2023 | 45.07% |
| Jun 30, 2023 | 68.81% |
| Mar 31, 2023 | 44.57% |
| Dec 31, 2022 | -10.90% |
| Sep 30, 2022 | -7.21% |
| Jun 30, 2022 | -5.11% |
| Mar 31, 2022 | -34.86% |
| Dec 31, 2021 | 27.84% |
| Sep 30, 2021 | -4.62% |
| Jun 30, 2021 | -3.83% |
| Mar 31, 2021 | 19.59% |
| Dec 31, 2020 | 17.05% |
| Sep 30, 2020 | 33.52% |
| Jun 30, 2020 | 30.44% |
| Mar 31, 2020 | -24.82% |
| Dec 31, 2019 | -21.78% |
| Sep 30, 2019 | -12.68% |
| Jun 30, 2019 | -16.27% |
| Mar 31, 2019 | -59.69% |
| Dec 31, 2018 | -64.73% |
| Sep 30, 2018 | -144.80% |
| Jun 30, 2018 | -1,150.66% |
| Mar 31, 2018 | -347.21% |